Two new omicron subvariants, BQ.1 and BQ.1.1, are quickly gaining traction in the US, collectively accounting for 27% of infections as of October 29. Both are descendants of BA.5, the omicron variant that has dominated around ...
Oct 31, 2022
0
12
A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science.
Oct 27, 2022
0
30
A subset of health care workers vaccinated against COVID-19 had unexpectedly low responses to the immunizations, according to Cedars-Sinai investigators. The findings of the new study are published in iScience.
Oct 26, 2022
0
55
By now more than 70% of the UK population have received a third COVID vaccination, or a booster. Many people who are older or at higher risk from COVID have had a fourth or even a fifth dose. But for how long and how often ...
Oct 24, 2022
0
5
Boston University is refuting a series of misleading claims about research at the University's National Emerging Infectious Diseases Laboratories (NEIDL). The reports, which first appeared on Monday in the United Kingdom's ...
Oct 19, 2022
0
4
A vaccine design approach that could protect against new variants of SARS-CoV-2 (the virus that causes COVID-19) but also potentially protects against other coronaviruses is one step closer to reality as a result of Penn ...
Oct 18, 2022
0
170
An entirely new approach to monoclonal antibody therapy shows that targeting the more genetically stable internal protein of the SARS-CoV-2 virus rather than the surface spike protein can also clear SARS-CoV-2, reports a ...
Oct 14, 2022
0
60
University of Maryland School of Medicine researchers have identified how multiple genes of SARS-CoV-2 affect disease severity, which could lead to new ways in how we develop future vaccines or develop newer treatments. The ...
Oct 7, 2022
1
54
Scientists at Scripps Research, IAVI, the Ragon Institute and Moderna, Inc., have come together to make critical advances in developing an effective vaccine against human immunodeficiency virus (HIV).
Oct 3, 2022
0
56
A Brazilian study published in the journal PNAS describes some of the effects infection by SARS-CoV-2 can have on the central nervous system. A preliminary version (not yet peer-reviewed) posted in 2020 was one of the first ...
Oct 1, 2022
0
670
